Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 31, 2007 - Issue 4
63
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Survival of Thalassemic Patients Referred to the Boo Ali Sina Teaching Hospital, Sari, Iran

, , , &
Pages 453-462 | Received 24 Jan 2007, Accepted 31 Mar 2007, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Margaret Locke, Paavani S. Reddy & Sherif M. Badawy. (2022) Adherence to Iron Chelation Therapy among Adults with Thalassemia: A Systematic Review. Hemoglobin 46:4, pages 201-213.
Read now
Masood Bazrgar, Farah Peiravian, Fatemeh Abedpour & Mehran Karimi. (2011) Causes for Hospitalization and Death in Iranian Patients with β-Thalassemia Major. Pediatric Hematology and Oncology 28:2, pages 134-139.
Read now
Ghasemali Khorasani, Mehrnoosh Kosaryan, Koorosh Vahidshahi, Sepideh Shakeri & Mohamad Mehdi Nasehi. (2008) Results of the National Program for Prevention of β-Thalassemia Major in the Iranian Province of Mazandaran. Hemoglobin 32:3, pages 263-271.
Read now

Articles from other publishers (11)

Nawsherwan Sadiq Mohammed. (2022) Protein C and S levels in patients with Thalassemia intermedia. Journal of Medicine and Life 15:11, pages 1415-1418.
Crossref
Fizza Iftikhar, Hamad Ali & Syed Ghulam Musharraf. (2019) Cinchona alkaloids as natural fetal hemoglobin inducing agents in human erythroleukemia cells. RSC Advances 9:31, pages 17551-17559.
Crossref
Alireza Ansari-Moghaddam, Hossein Ali Adineh, Iraj Zareban, Mehdi Mohammadi & Mahtab Maghsoodlu. (2018) The survival rate of patients with beta-thalassemia major and intermedia and its trends in recent years in Iran. Epidemiology and Health 40, pages e2018048.
Crossref
Samir K. Ballas, Amer M. Zeidan, Vu H. Duong, Michelle DeVeaux & Matthew M. Heeney. (2018) The effect of iron chelation therapy on overall survival in sickle cell disease and β-thalassemia: A systematic review. American Journal of Hematology 93:7, pages 943-952.
Crossref
Hadi Darvishi Khezri, Ebrahim Salehifar, Mehrnoush Kosaryan, Aily Aliasgharian, Hossein Jalali & Arash Hadian Amree. (2016) Potential Effects of Silymarin and Its Flavonolignan Components in Patients with β -Thalassemia Major: A Comprehensive Review in 2015 . Advances in Pharmacological Sciences 2016, pages 1-8.
Crossref
Mehrnoush Kosaryan & Aily Aliasgharian. (2015) Decrease of Hepatitis C Burden in Patients With Transfusion Dependent Beta Thalassemia Major, Thalassemia Research Center, 1995 – 2014. Journal of Pediatrics Review 3:2.
Crossref
Abdolreza Rajaeefard, Mahmoud Hajipour, Hamid Reza Tabatabaee, Jafar Hassanzadeh, Shahab Rezaeian, Zahra Moradi, Mehdi Sharafi, Mohsen Shafiee, Ali Semati, Sanaz Safaei & Maryam Soltani. (2015) Analysis of survival data in thalassemia patients in Shiraz, Iran. Epidemiology and Health 37, pages e2015031.
Crossref
Mandana Zafari & Mehrnoush Kosaryan. (2014) Marriage and child bearing in patients with transfusion-dependent thalassemia major. Journal of Obstetrics and Gynaecology Research 40:8, pages 1978-1982.
Crossref
Pattara Leelahavarong, Usa Chaikledkaew, Suradej Hongeng, Vijj Kasemsup, Yoel Lubell & Yot Teerawattananon. (2010) A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand. BMC Health Services Research 10:1.
Crossref
H. Karami, K. Vahidshahi, M. Kosarian, H. Karami, S. Shahmohamm, M. Dabirian, M. Vafainezha, E. Yousefi, L. Sarparast, R. Alizade, M. Mahdavi & M.B. Hashemi. (2010) Assessment of Coagulation State and its Related Factors in Thalassemia Intermedia Patients Referred to Thalassemia Research Center at Booali Sina Hospital Sari/IR Iran in 2007. Pakistan Journal of Biological Sciences 13:9, pages 448-451.
Crossref
R.H.B. Meyboom. 2010. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions 425 435 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.